Embolic Protection Devices Market: By Type, By Material, By Indication, By Application, By End User and Regional Forecast 2020-2031
Embolic Protection Devices Market size was valued at US$ 655.1 million in 2024 and is expected to reach US$ 1,144.8 million by 2031, growing at a significant CAGR of 8.3% from 2025-2031. Rising demand for minimally invasive procedures, funding and investments for R&D on embolic protection devices, favorable reimbursement policies for these systems, growing burden of chronic diseases, consumer awareness regarding embolic devices, rise in number of trans-catheter aortic valve replacement (TAVR) procedures and technological advancements in embolic protection devices are some key factors fostering the market growth.
However, factors such as stringent regulatory scenario, high cost of the devices and presence of alternative treatment are hindering the market growth. In addition, high growth in emerging economies provides huge growth opportunity for the market. This report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition.
Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global market report include suppliers, manufacturers, marketers, policy makers, and service providers engaged in global embolic protection devices products.
Study Period
2025-2031Base Year
2024CAGR
8.3%Largest Market
Asia-PacificFastest Growing Market
Europe
The growth of transcatheter aortic valve replacement (TAVR) has developed as a support for patients considered to be impossible offering together development in indications and statistically momentous mortality assistance. Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure to replace a narrowed aortic valve that fails to open properly. Rapid advances in technology have propelled TAVR to the forefront of treatment options. The initially reported periprocedural neurological events rates associated with transcatheter aortic valve replacement (TAVR) raised concerns that ultimately led to the development and to the clinical research of novel embolic protection devices (EPD). Embolic protection devices in TAVR appear to reduce the 30-day risk of stroke but do not affect 30 day mortality.
Asia Pacific accounted for larger revenue share in global embolic protection devices market with a CAGR of XX% and is expected to grow over the forecast years. The growth in this region can be attributed to rapid urbanization together with changing lifestyles of the people, quickly improving healthcare infrastructure and large target population base. China and India are the major contributors for the growth of the market in the region as there is an increasing government support and healthcare reforms.
Europe held substantial market share during estimated period owing to investments from public and private entities, rising disposable income and improvised healthcare infrastructure.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2024 |
US$ 655.1 million |
|
Market Size in 2031 |
US$ 1,144.8 million |
|
Market CAGR |
8.3% |
|
By Type |
|
|
By Material |
|
|
By Indication |
|
|
By Application |
|
|
By Region |
|
Download Free Sample Report
The embolic protection devices market size was valued at US$ 655.1 million in 2024 and is expected to reach US$ 1,144.8 million by 2031, growing at a significant CAGR of 8.3% from 2025-2031
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
| 1. Executive Summary |
| 2. Global Embolic Protection Devices Market Introduction |
| 2.1.Global Embolic Protection Devices Market - Taxonomy |
| 2.2.Global Embolic Protection Devices Market - Definitions |
| 2.2.1.Type |
| 2.2.2.Material |
| 2.2.3.Indication |
| 2.2.4.Application |
| 2.2.5.Region |
| 3. Global Embolic Protection Devices Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Embolic Protection Devices Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Embolic Protection Devices Market By Type , 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Distal Filter Devices |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Distal Occlusion Devices |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Proximal Occlusion Devices |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Global Embolic Protection Devices Market By Material, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Nitinol |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Polyurethane |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7. Global Embolic Protection Devices Market By Indication, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Percutaneous Coronary Intervention |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Carotid Artery Diseases Saphenous Vein Graft Disease |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Transcatheter Aortic Valve Replacement |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Other Indications |
| 7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Global Embolic Protection Devices Market By Application, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. Cardiovascular Diseases |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Neurovascular Diseases |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Peripheral Diseases |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9. Global Embolic Protection Devices Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10. North America Embolic Protection Devices Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 10.1. Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Distal Filter Devices |
| 10.1.2.Distal Occlusion Devices |
| 10.1.3.Proximal Occlusion Devices |
| 10.2. Material Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Nitinol |
| 10.2.2.Polyurethane |
| 10.3. Indication Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Percutaneous Coronary Intervention |
| 10.3.2.Carotid Artery Diseases Saphenous Vein Graft Disease |
| 10.3.3.Transcatheter Aortic Valve Replacement |
| 10.3.4.Other Indications |
| 10.4. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Cardiovascular Diseases |
| 10.4.2.Neurovascular Diseases |
| 10.4.3.Peripheral Diseases |
| 10.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11. Europe Embolic Protection Devices Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Distal Filter Devices |
| 11.1.2.Distal Occlusion Devices |
| 11.1.3.Proximal Occlusion Devices |
| 11.2. Material Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Nitinol |
| 11.2.2.Polyurethane |
| 11.3. Indication Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Percutaneous Coronary Intervention |
| 11.3.2.Carotid Artery Diseases Saphenous Vein Graft Disease |
| 11.3.3.Transcatheter Aortic Valve Replacement |
| 11.3.4.Other Indications |
| 11.4. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Cardiovascular Diseases |
| 11.4.2.Neurovascular Diseases |
| 11.4.3.Peripheral Diseases |
| 11.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12. Asia Pacific (APAC) Embolic Protection Devices Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Distal Filter Devices |
| 12.1.2.Distal Occlusion Devices |
| 12.1.3.Proximal Occlusion Devices |
| 12.2. Material Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Nitinol |
| 12.2.2.Polyurethane |
| 12.3. Indication Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Percutaneous Coronary Intervention |
| 12.3.2.Carotid Artery Diseases Saphenous Vein Graft Disease |
| 12.3.3.Transcatheter Aortic Valve Replacement |
| 12.3.4.Other Indications |
| 12.4. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Cardiovascular Diseases |
| 12.4.2.Neurovascular Diseases |
| 12.4.3.Peripheral Diseases |
| 12.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13. Middle East and Africa (MEA) Embolic Protection Devices Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Distal Filter Devices |
| 13.1.2.Distal Occlusion Devices |
| 13.1.3.Proximal Occlusion Devices |
| 13.2. Material Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Nitinol |
| 13.2.2.Polyurethane |
| 13.3. Indication Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Percutaneous Coronary Intervention |
| 13.3.2.Carotid Artery Diseases Saphenous Vein Graft Disease |
| 13.3.3.Transcatheter Aortic Valve Replacement |
| 13.3.4.Other Indications |
| 13.4. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Cardiovascular Diseases |
| 13.4.2.Neurovascular Diseases |
| 13.4.3.Peripheral Diseases |
| 13.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14. Latin America Embolic Protection Devices Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 14.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Distal Filter Devices |
| 14.1.2.Distal Occlusion Devices |
| 14.1.3.Proximal Occlusion Devices |
| 14.2. Material Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Nitinol |
| 14.2.2.Polyurethane |
| 14.3. Indication Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Percutaneous Coronary Intervention |
| 14.3.2.Carotid Artery Diseases Saphenous Vein Graft Disease |
| 14.3.3.Transcatheter Aortic Valve Replacement |
| 14.3.4.Other Indications |
| 14.4. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Cardiovascular Diseases |
| 14.4.2.Neurovascular Diseases |
| 14.4.3.Peripheral Diseases |
| 14.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Boston Scientific (US) |
| 15.2.2.Medtronic Ireland) |
| 15.2.3.Abbott (US) |
| 15.2.4.Cordis (A Cardinal Health Company) (US) |
| 15.2.5.Allium Medical Solutions (Israel) |
| 15.2.6.Contego Medical (US) |
| 15.2.7.L. Gore & Associates (US) |
| 15.2.8.Silk Road Medical (US) |
| 15.2.9.Claret Medical (US) |
| 15.2.10.AngioSlide (Israel) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Sample
